We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
TESTIS CANCER - Interactive survival scatter ploti
The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.
The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".
Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.
Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.
& Survival analysisi
Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.
Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.
: Best expression cut offi
Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .
When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.
Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.
Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.
: N/A P scorei
Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.
N/A 5-year survival highi
5-year survival for patients with higher expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A 5-year survival lowi
5-year survival for patients with lower expression than the expression cutoff.
For melanoma and glioma, 3-year survival is shown.
N/A
TCGA RNA samplesi
RNA-seq data is reported as median FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .
Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.
Average FPKM
6467.1
Number of samples
134
Samples
Sample
Description
FPKM
TCGA-ZM-AA05-01A
36 years, male, white, stage:iic, alive, 1126 days
73874.7
TCGA-ZM-AA0F-01A
35 years, male, white, stage:ia, alive, 681 days
40515.8
TCGA-ZM-AA0H-01A
50 years, male, white, stage:is, alive, 1736 days
36307.4
TCGA-ZM-AA06-01A
45 years, male, white, stage:ib, alive, 1498 days
36280.0
TCGA-XE-AAOL-01A
38 years, male, black or african american, stage:i, alive, 13 days
34204.4
TCGA-ZM-AA0E-01A
39 years, male, white, stage:ia, alive, 811 days
31063.8
TCGA-ZM-AA0N-01A
44 years, male, white, stage:ib, alive, 634 days
23419.3
TCGA-XE-AAO6-01A
47 years, male, white, stage:ia, alive, 240 days
21993.6
TCGA-ZM-AA0B-01A
32 years, male, white, stage:ia, alive, 838 days
18648.0
TCGA-ZM-AA0D-01A
34 years, male, white, stage:ia, alive, 848 days
15129.9
TCGA-XE-AAO4-01A
40 years, male, white, stage:ia, alive, 367 days
12309.8
TCGA-2G-AAGG-01A
20 years, male, white, stage:iiic, alive, 2611 days
11746.1
TCGA-YU-A90S-01A
26 years, male, white, stage:ia, alive, 971 days
10558.1
TCGA-W4-A7U4-01A
23 years, male, white, alive, 738 days
8458.8
TCGA-2G-AAG6-01A
24 years, male, white, stage:is, alive, 2231 days
8017.3
TCGA-YU-A94I-01A
66 years, male, stage:ia, alive, 536 days
7696.3
TCGA-YU-A90Y-01A
23 years, male, black or african american, stage:iiic, dead, 17 days
7689.4
TCGA-XE-AAOJ-01A
24 years, male, white, stage:is, alive, 1550 days
7608.3
TCGA-WZ-A8D5-01A
38 years, male, white, alive, 774 days
7156.4
TCGA-YU-A90P-01A
25 years, male, white, stage:ia, alive, 2069 days
7017.4
TCGA-2G-AAGV-01A
23 years, male, white, alive, 4527 days
6506.7
TCGA-2G-AAG5-01A
36 years, male, white, stage:is, alive, 2299 days
6482.8
TCGA-2G-AAGE-01A
21 years, male, white, stage:is, alive, 2478 days
6187.9
TCGA-XY-A89B-01A
35 years, male, white, stage:ia, alive, 471 days
6142.7
TCGA-2G-AAKL-01A
26 years, male, white, stage:ii, alive, 7023 days
6093.2
TCGA-4K-AA1I-01A
26 years, male, white, stage:ia, alive, 3 days
6028.1
TCGA-S6-A8JY-01A
27 years, male, white, stage:is, alive, 278 days
6008.5
TCGA-2G-AAG0-01A
23 years, male, white, stage:is, alive, 1529 days
5934.3
TCGA-VF-A8AB-01A
31 years, male, black or african american, stage:ia, alive, 760 days
5757.8
TCGA-VF-A8AE-01A
39 years, male, white, stage:ia, alive, 727 days
5705.9
TCGA-2G-AAGA-01A
38 years, male, white, stage:iia, alive, 2439 days
5665.1
TCGA-XE-A8H4-01A
23 years, male, white, stage:ia, alive, 559 days
5603.7
TCGA-XE-AAOB-01A
27 years, male, white, stage:is, dead, 513 days
5598.1
TCGA-2G-AAKM-01A
14 years, male, white, stage:ii, dead, 6972 days
5577.8
TCGA-2G-AAH2-01A
20 years, male, white, stage:is, alive, 6060 days
5559.1
TCGA-XE-AAOC-01A
31 years, male, white, stage:ia, alive, 270 days
5510.1
TCGA-2G-AAFY-01A
24 years, male, white, stage:iia, alive, 1099 days
5482.4
TCGA-VF-A8AD-01A
36 years, male, white, stage:ib, alive, 1006 days
5423.9
TCGA-YU-AA4L-01A
27 years, male, black or african american, stage:iiic, alive, 1573 days
5379.1
TCGA-2G-AAGY-01A
28 years, male, white, stage:is, alive, 5329 days
5314.5
TCGA-XE-AAOD-01A
39 years, male, white, stage:ib, alive, 2058 days
5308.4
TCGA-2G-AAG3-01A
53 years, male, white, stage:is, alive, 1593 days
5283.4
TCGA-2G-AAL7-01A
32 years, male, white, stage:is, alive, 3991 days
5197.1
TCGA-VF-A8A8-01A
18 years, male, white, stage:ia, alive, 1131 days
5043.8
TCGA-2G-AAG8-01A
21 years, male, white, stage:ib, alive, 2289 days
5036.5
TCGA-2G-AAFL-01A
35 years, male, white, stage:ib, alive, 750 days
4985.1
TCGA-WZ-A7V4-01A
28 years, male, white, stage:i, alive, 894 days
4982.8
TCGA-2G-AAFM-01A
31 years, male, white, stage:iia, alive, 503 days
4979.6
TCGA-XE-AANJ-01A
39 years, male, white, stage:is, alive, 2007 days
4898.0
TCGA-4K-AAAL-01A
31 years, male, white, stage:is, alive, 483 days
4872.6
TCGA-2G-AAFE-01A
37 years, male, white, stage:iia, alive, 4702 days
4858.1
TCGA-4K-AA1H-01A
26 years, male, white, stage:ia, alive, 518 days
4821.1
TCGA-SN-A84W-01A
30 years, male, white, stage:is, alive, 293 days
4793.5
TCGA-2G-AAGP-01A
33 years, male, white, stage:iia, alive, 4018 days
4767.0
TCGA-S6-A8JX-01A
27 years, male, white, stage:ib, alive, 552 days
4698.4
TCGA-2G-AAFJ-01A
23 years, male, asian, alive, 792 days
4623.0
TCGA-2G-AAG9-01A
25 years, male, white, stage:iiib, alive, 2234 days
4595.8
TCGA-VF-A8A9-01A
31 years, male, white, stage:ia, alive, 1119 days
4518.6
TCGA-2G-AAFH-01A
38 years, male, white, stage:iib, alive, 1375 days
4450.1
TCGA-2G-AAFN-01A
26 years, male, white, stage:iiib, alive, 773 days
4439.7
TCGA-2G-AAGZ-01A
27 years, male, white, stage:iiia, alive, 5233 days
4425.1
TCGA-2G-AAGF-01A
28 years, male, white, stage:is, alive, 2734 days
4422.4
TCGA-XE-A8H1-01A
24 years, male, white, stage:is, alive, 209 days
4408.4
TCGA-2G-AAGN-01A
41 years, male, white, stage:iiib, alive, 3656 days
4311.3
TCGA-2G-AALP-01A
43 years, male, white, stage:iiib, alive, 2645 days
4291.1
TCGA-2G-AAGO-01A
41 years, male, white, stage:is, alive, 4026 days
4275.4
TCGA-2G-AAFI-01A
41 years, male, white, stage:ib, alive, 675 days
4212.2
TCGA-2G-AAKG-01A
22 years, male, white, stage:i, alive, 6598 days
4196.9
TCGA-2G-AAFG-01A
30 years, male, white, stage:is, alive, 6183 days
4168.1
TCGA-2G-AAG7-01A
33 years, male, white, stage:is, alive, 2475 days
4157.5
TCGA-2G-AAGC-01A
28 years, male, white, stage:is, alive, 2585 days
4152.5
TCGA-X3-A8G4-01A
33 years, male, white, stage:is, alive, 856 days
4127.2
TCGA-2G-AAH0-01A
30 years, male, white, stage:is, alive, 5477 days
4019.7
TCGA-2G-AAKH-01A
19 years, male, white, stage:ii, alive, 6862 days
3956.1
TCGA-XY-A8S3-01B
24 years, male, white, stage:is, alive, 843 days
3928.0
TCGA-SN-A6IS-01A
26 years, male, white, stage:is, alive, 496 days
3917.2
TCGA-YU-A90W-01A
45 years, male, white, stage:ia, alive, 1113 days
3893.5
TCGA-XE-AANI-01A
37 years, male, white, stage:is, alive, 1041 days
3888.0
TCGA-2G-AAHA-01A
48 years, male, white, stage:ib, alive, 3349 days
3860.3
TCGA-2G-AAGI-01A
33 years, male, white, stage:is, alive, 3137 days
3854.3
TCGA-YU-A94D-01A
28 years, male, stage:iiib, alive, 2167 days
3726.9
TCGA-2G-AAF8-01A
33 years, male, white, stage:ia, alive, 3911 days
3711.1
TCGA-2G-AAGW-01A
38 years, male, white, stage:is, alive, 4899 days
3693.0
TCGA-SN-A84Y-01A
18 years, male, white, stage:is, alive, 524 days
3691.6
TCGA-YU-AA61-01A
29 years, male, white, stage:is, alive, 864 days
3668.3
TCGA-XE-A8H5-01A
29 years, male, stage:is, alive, 1217 days
3641.0
TCGA-2G-AAKD-01A
18 years, male, white, stage:iii, alive, 6340 days
3606.9
TCGA-2G-AAGS-01A
39 years, male, white, stage:iiib, alive, 4816 days
3606.5
TCGA-WZ-A7V3-01A
20 years, male, white, stage:i, alive, 753 days
3584.2
TCGA-W4-A7U3-01A
26 years, male, white, alive, 149 days
3571.0
TCGA-2G-AAGJ-01A
28 years, male, black or african american, stage:ia, alive, 2938 days
3503.1
TCGA-WZ-A7V5-01A
27 years, male, white, stage:i, alive, 1061 days
3422.9
TCGA-2G-AAFV-01A
31 years, male, white, stage:is, alive, 1389 days
3400.2
TCGA-YU-A90Q-01A
21 years, male, stage:ib, alive, 1964 days
3394.0
TCGA-XE-AAOF-01A
50 years, male, asian, stage:ia, alive, 1268 days
3329.6
TCGA-VF-A8AA-01A
51 years, male, white, stage:i, alive, 1146 days
3325.8
TCGA-2G-AAEX-01A
38 years, male, white, stage:is, alive, 1259 days
3310.2
TCGA-2G-AAGM-01A
51 years, male, white, stage:is, alive, 3891 days
3308.9
TCGA-2G-AAH4-01A
34 years, male, white, stage:ii, alive, 6210 days
3298.5
TCGA-2G-AAFO-01A
33 years, male, white, stage:iia, alive, 685 days
3229.8
TCGA-YU-A912-01A
34 years, male, black or african american, stage:iiic, alive, 866 days
3182.3
TCGA-2X-A9D5-01A
49 years, male, white, stage:i, alive, 435 days
3121.6
TCGA-2G-AAHC-01A
33 years, male, white, stage:is, alive, 5539 days
3025.2
TCGA-2G-AAH3-01A
20 years, male, white, stage:i, alive, 1822 days
3014.1
TCGA-2G-AAGX-01A
22 years, male, white, stage:ia, alive, 5514 days
2998.7
TCGA-2G-AAFZ-01A
32 years, male, white, stage:iii, alive, 1353 days
2932.6
TCGA-2G-AAHG-01A
25 years, male, white, stage:i, alive, 1819 days
2875.8
TCGA-2G-AAGT-01A
30 years, male, white, stage:is, alive, 4406 days
2831.0
TCGA-XE-A9SE-01A
35 years, male, white, stage:ia, alive, 708 days
2827.6
TCGA-XY-A8S2-01A
67 years, male, white, stage:i, alive, 672 days
2735.1
TCGA-W4-A7U2-01A
26 years, male, white, alive, 1263 days
2726.7
TCGA-2X-A9D6-01A
42 years, male, white, stage:i, alive, 607 days
2703.1
TCGA-SN-A84X-01A
21 years, male, white, stage:is, alive, 312 days
2642.9
TCGA-2G-AAF4-01A
30 years, male, white, stage:i, alive, 2315 days
2630.4
TCGA-XE-AAO3-01A
33 years, male, asian, stage:i, alive, 2857 days
2604.2
TCGA-XE-AANR-01A
24 years, male, white, stage:i, alive, 14 days
2570.8
TCGA-S6-A8JW-01A
37 years, male, white, stage:is, alive, 698 days
2560.6
TCGA-2G-AAHN-01A
32 years, male, white, stage:i, alive, 6445 days
2553.1
TCGA-SB-A6J6-01A
22 years, male, white, stage:ia, alive, 413 days
2539.3
TCGA-SB-A76C-01A
38 years, male, white, alive, 42 days
2521.6
TCGA-XY-A9T9-01A
37 years, male, white, stage:is, alive, 281 days
2452.6
TCGA-XE-AANV-01A
52 years, male, stage:ib, alive, 1701 days
2409.3
TCGA-2G-AAHT-01A
32 years, male, white, stage:is, alive, 542 days
2301.0
TCGA-2G-AAH8-01A
45 years, male, white, stage:iiic, alive, 2248 days
2230.3
TCGA-2G-AAGK-01A
20 years, male, white, stage:is, alive, 3621 days
2146.3
TCGA-2G-AAF6-01A
28 years, male, white, stage:is, alive, 3491 days
2089.1
TCGA-VF-A8AC-01A
29 years, male, white, stage:ia, alive, 1083 days
2040.4
TCGA-2G-AAHL-01A
26 years, male, white, stage:i, alive, 7081 days
1901.7
TCGA-2G-AAL5-01A
31 years, male, white, stage:i, alive, 7437 days
1881.1
TCGA-2G-AAEW-01A
31 years, male, white, stage:is, dead, 618 days
1807.1
TCGA-SO-A8JP-01A
29 years, male, white, stage:i, alive, 540 days
1530.3
TCGA-2G-AAF1-01A
28 years, male, asian, stage:is, alive, 1403 days
1260.5
TCGA-4K-AA1G-01A
34 years, male, white, stage:is, alive, 436 days
1108.1
TCGA-2G-AAHP-01A
31 years, male, white, stage:is, alive, 5667 days
541.0
Show allShow less
TESTIS CANCER - Protein expressioni
A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.
Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.
Antibody stainingi
Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high. This score is based on the staining intensity and fraction of stained cells.